title: Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain. Electronic address: marta.hernandez.conde@gmail.com.
authors.forename: Marta
authors.initials: M
authors.lastname: Hernández
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Yago
authors.initials: Y
authors.lastname: González-Lama
authors.affiliation: Infectious Diseases Unit, Internal Medicine Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Ramos
authors.affiliation: Microbiology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Rocío
authors.initials: R
authors.lastname: Martínez-Ruiz
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Marta
authors.initials: M
authors.lastname: Calvo
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Virginia
authors.initials: V
authors.lastname: Matallana
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: María Isabel
authors.initials: MI
authors.lastname: Vera
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Suarez
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Isabel
authors.initials: I
authors.lastname: Blázquez
authors.affiliation: IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Abreu
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D004197:Disease Reservoirs; D004198:Disease Susceptibility; D004285:Dogs; D006801:Humans; D016867:Immunocompromised Host; D000069285:Infliximab / Q000009:adverse effects* / Q000627:therapeutic use; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000635:transmission; D008297:Male; D009395:Nephritis, Interstitial / Q000150:complications / Q000188:drug therapy; D009894:Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000635:transmission; D064927:Tick Bites / Q000469:parasitology; D015047:Zoonoses
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000981:Antiprotozoal Agents; D000666:Amphotericin B; D000069285:Infliximab